Inventor · disambiguated record
William Muldoon
Also filed as: MULDOON WILLIAM · MULDOON WILLIAM THOMAS
2 granted patents·6 pending applications·72 citations·filing 1999–2007
67Inventor score
Files withSMITHKLINE BEECHAM PLC3SMITHKLINE BEECHAM CORP2SMITHKLINE BEECHAM CORP AND SM1SMITHKLINE BEECHAM P L C & SMI1SMITHKLINE BEECHAM P L C AND S1
Top patents by PatentIndex Score
8 records- 0187US6468560B2Controlled release dosage form of [R-(Z)]-α-(methoxyimino)-α-(1-azabicyclo[2.2.2]oct-3yl) acetonitrile monohydrochlorideSMITHKLINE BEECHAM PLC·Filed 2001·Granted Oct 22, 2002·40 cites·4 claims
- 0268US6451343B1Composition for treating dementia and Alzheimer's diseaseSMITHKLINE BEECHAM CORP·Filed 1999·Granted Sep 17, 2002·32 cites·27 claims
- 0363US2007281023A1Pharmaceutical composition for modified release insulin sensitiserSMITHKLINE BEECHAM P L C & SMI·Filed 2007·Application pending·0 cites
- 0457US2004091531A1Novel composition and useSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 0555US2003153607A1Novel composition and useSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 0655US2005136111A1Novel composition and useSMITHKLINE BEECHAM P L C AND S·Filed 2005·Application pending·0 cites
- 0750US2003157169A1Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile monohydrochlorideSMITHKLINE BEECHAM CORP AND SM·Filed 2002·Application pending·0 cites
- 0849US2001003588A1Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochlorideSMITHKLINE BEECHAM CORP·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Muldoon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →